CoChat

Serum Galactomannan Versus a Combination of Galactomannan and Polymerase Chain Reaction-Based Aspergillus DNA Detection for Early Therapy of Invasive Aspergillosis in High-Risk Hematological Patients: A Randomized Controlled Trial

Open access
Aguado, J. M., Vazquez, L., Fernandez-Ruiz, M., Villaescusa, T., Ruiz-Camps, I., Barba, P., Silva, J. T., Batlle, M., Solano, C., Gallardo, D., Heras, I., Polo, M., Varela, R., Vallejo, C., Olave, T., Lopez-Jimenez, J., Rovira, M., Parody, R., Cuenca-Estrella, M., for the PCRAGA Study Group, the Spanish Stem Cell Transplantation Group, the Study Group of Medical Mycology of the Spanish Society of Clinical Microbiology and Infectious Diseases, and the Spanish Network for Research in Infectious Diseases, Zarzuela, M. P., Candel Gonzalez, F. J., Amador, P. M., Mediavilla, J. D., Camps, I. R., Barba, P., Castillo, N., Martin, M. T., Soriano, J. A., Fernando, I. H., Castilla-Llorente, C., Cesteros, R., Rodriguez Mondejar, M. R., Vazquez, L., Villaescusa, T., Caballero, D., Garcia, J. E., Garcia, I. G., de la Mano Gonzalez, S., Fernandez Garcia-Hierro, J. M., Solano, C., Tormo, M., Navarro, D., Angel Molla, M., Vallejo, C., Gonzalez, A. J., Gonzalez, S., Gonzalez, A. P., Palomo, P., Porras, R. P., Batlle, M., Gallardo, D., Guardia Sanchez, R., Rosario Varela, M., Olave Rubio, M. T., Jimenez, J. L., Tarrats, M. R., Grande, M. S.-L., Fernandez-Aviles, F., Aguado, J. M., Fernandez-Ruiz, M., Silva, J. T., Cuenca-Estrella, M., Buitrago, M. J., Amador, T. M., Bernal-Martinez, L. · 2015 · Clinical Infectious Diseases
Cited by 158

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The benefit of the combination of serum galactomannan (GM) assay and polymerase chain reaction (PCR)-based detection of serum Aspergillus DNA for the early diagnosis and therapy of invasive aspergillosis (IA) in high-risk hematological patients remains unclear. METHODS: We performed an open-label, controlled, parallel-group randomized trial in 13 Spanish centers. Adult patients with acute myeloid leukemia and myelodysplastic syndrome on induction therapy or allogeneic hematopoietic stem cell transplant recipients were randomized (1:1 ratio) to 1 of 2 arms: "GM-PCR group" (the results of serial serum GM and PCR assays were provided to treating physicians) and "GM group" (only the results of serum GM were informed). Positivity in either assay prompted thoracic computed tomography scan and initiation of antifungal therapy. No antimold prophylaxis was permitted. RESULTS: Overall, 219 patients underwent randomization (105 in the GM-PCR group and 114 in the GM group). The cumulative incidence of "proven" or "probable" IA (primary study outcome) was lower in the GM-PCR group (4.2% vs 13.1%; odds ratio, 0.29 [95% confidence interval, .09-.91]). The median interval from the start of monitoring to the diagnosis of IA was lower in the GM-PCR group (13 vs 20 days; P = .022), as well as the use of empirical antifungal therapy (16.7% vs 29.0%; P = .038). Patients in the GM-PCR group had higher proven or probable IA-free survival (P = .027). CONCLUSIONS: A combined monitoring strategy based on serum GM and Aspergillus DNA was associated with an earlier diagnosis and a lower incidence of IA in high-risk hematological patients. Clinical Trials Registration. NCT01742026.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciu833

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 158

Metadata

Authors
Aguado, J. M., Vazquez, L., Fernandez-Ruiz, M., Villaescusa, T., Ruiz-Camps, I., Barba, P., Silva, J. T., Batlle, M., Solano, C., Gallardo, D., Heras, I., Polo, M., Varela, R., Vallejo, C., Olave, T., Lopez-Jimenez, J., Rovira, M., Parody, R., Cuenca-Estrella, M., for the PCRAGA Study Group, the Spanish Stem Cell Transplantation Group, T. S. G. O. M. M. O. T. S. S. O. C. M. A. I. D., Zarzuela, M. P., Candel Gonzalez, F. J., Amador, P. M., Mediavilla, J. D., Camps, I. R., Barba, P., Castillo, N., Martin, M. T., Soriano, J. A., Fernando, I. H., Castilla-Llorente, C., Cesteros, R., Rodriguez Mondejar, M. R., Vazquez, L., Villaescusa, T., Caballero, D., Garcia, J. E., Garcia, I. G., de la Mano Gonzalez, S., Fernandez Garcia-Hierro, J. M., Solano, C., Tormo, M., Navarro, D., Angel Molla, M., Vallejo, C., Gonzalez, A. J., Gonzalez, S., Gonzalez, A. P., Palomo, P., Porras, R. P., Batlle, M., Gallardo, D., Guardia Sanchez, R., Rosario Varela, M., Olave Rubio, M. T., Jimenez, J. L., Tarrats, M. R., Grande, M. S.-L., Fernandez-Aviles, F., Aguado, J. M., Fernandez-Ruiz, M., Silva, J. T., Cuenca-Estrella, M., Buitrago, M. J., Amador, T. M., & Bernal-Martinez, L.
Venue
Clinical Infectious Diseases
Published
2014-10-21
Volume
60
Issue
3
Pages
405-414
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2014423588
Cited by
158
References
5
FWCI
16.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.